Cell Viability Assays Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Cell Viability Assays Market Forecast and It is Segmented by Product (Consumables (Reagents, Assay Kits, Other Consumables), Instruments (Automated Cell Counters, Flow Cytometers, Spectrophotometers, Other Instruments)), by Application (Drug Discovery and Development, Stem Cell Research, Clinical and Diagnostic Applications, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The Market Values are Provided in Terms of (in USD) for the Above Segments.

Cell Viability Assays Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cell Viability Assays Market Size

Cell Viability Assays Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 1.87 Billion
Market Size (2030) USD 2.72 Billion
CAGR (2025 - 2030) 7.70 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Cell Viability Assays Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Cell Viability Assays Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cell Viability Assays Market Analysis

The Cell Viability Assays Market size is estimated at USD 1.87 billion in 2025, and is expected to reach USD 2.72 billion by 2030, at a CAGR of 7.7% during the forecast period (2025-2030).

The COVID-19 pandemic significantly impacted the growth of the cell viability assay market, as most companies focused on developing cell-based therapies for COVID-19 treatment. For instance, according to the study published in Stem Cell Research & Therapy volume in January 2022, stem cell therapy and stem cell-derived organoid models got much attention as a new treatment and research method for COVID-19, and stem cells played a role in the battle against COVID-19. With the increase in the need for stem cell therapies, there was to be an increase in the need for cell viability assays; hence, the market grew during the pandemic. However, as the pandemic has subsided, the studied market is expected to have stable growth during the forecast period of the study.

Factors such as the growing burden of chronic and infectious diseases, rising demand for cell-based assays in research, and increasing focus on developing cell-based therapeutics drive global market growth. Moreover, chronic diseases and conditions are on the rise worldwide, which is expected to further enhance the usage of cell viability assays. As per the International Diabetes Federation Diabetes Altas, in 2021, nearly 573 million adults were living with diabetes worldwide, and the number is expected to reach 643 million by 2030 and 783 million by 2045. As chronic disorders are on the rise, there is a huge demand for assays, which are helping in the faster treatment and timely detection of patients' conditions.

In emerging markets, cancer and heart diseases are becoming the main causes of death due to urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. For instance, according to an article published by PubMed Central in March 2022, China is experiencing a greater incidence of cancers. In 2022, there were expected to be approximately 4,820,000 new cancer cases in China, of which the most common is lung cancer. Hence, the high prevalence of chronic diseases such as cancer is expected to boost the adoption of cell viability assays to develop more innovative drugs.

Moreover, developing new cell viability assays to meet the rising demand is also a major factor driving the market growth. For instance, according to an article published by PubMed Central in May 2022, a novel cell viability assay was developed, which can check cellular viability in real-time using supervised machine learning and intracellular dynamic activity data acquired in a label-free, non-invasive, and non-destructive manner. Thus, the rising developments, such as novel cell viability assays, are also expected to boost market growth.

However, the limitations of the assays are expected to impede the market growth.

Cell Viability Assays Industry Overview

The cell viability assays market is fragmented and competitive owing to the presence of various small and large market players. Some of the market players are Abcam PLC, Becton Dickinson & Company, Bio-Rad Laboratories, Biotek Instruments, Creative Bioarray, GE Healthcare, Merck KGaA, Perkin Elmer, Promega Corporation, and Thermo Fischer Scientific Inc.

Cell Viability Assays Market Leaders

  1. Thermo Fischer Scientific Inc.

  2. Merck KGaA

  3. Bio-Rad Laboratories

  4. Becton Dickinson & Company

  5. Abcam PLC

  6. *Disclaimer: Major Players sorted in no particular order
Cell Viability Assays Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cell Viability Assays Market News

  • September 2022: Nanolive launched the LIVE Cell Death Assay, an automated solution for profiling cell health, death, apoptosis, and necrosis.
  • March 2022: Biovica decided to establish a CLIA lab in San Diego, California. A location has been identified, and a lease for the premises has been signed. The lab will, after the clearance, offer DiviTumTKa-analysis to Biovica's customers in the United States.

Cell Viability Assays Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic and Infectious Diseases
    • 4.2.2 Rising Demand for Cell-based Assays in Research
    • 4.2.3 Increasing Focus on the Development of Cell-based Therapeutics
  • 4.3 Market Restraints
    • 4.3.1 Limitations of the Assays
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product
    • 5.1.1 Consumables
    • 5.1.1.1 Reagents
    • 5.1.1.2 Assay Kits
    • 5.1.1.3 Other Consumables
    • 5.1.2 By Instruments
    • 5.1.2.1 Automated Cell Counters
    • 5.1.2.2 Flow Cytometers
    • 5.1.2.3 Spectrophotometers
    • 5.1.2.4 Other Instruments
  • 5.2 By Application
    • 5.2.1 Drug Discovery and Development
    • 5.2.2 Stem Cell Research
    • 5.2.3 Clinical and Diagnostic Applications
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abcam PLC
    • 6.1.2 Becton Dickinson & Company
    • 6.1.3 Bio-Rad Laboratories
    • 6.1.4 Biotek Instruments
    • 6.1.5 Creative Bioarray
    • 6.1.6 GE Healthcare
    • 6.1.7 Merck KGaA
    • 6.1.8 Perkin Elmer
    • 6.1.9 Promega Corporation
    • 6.1.10 Thermo Fischer Scientific Inc.
    • 6.1.11 Canvax Biotech
    • 6.1.12 Creative Bioarray
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cell Viability Assays Industry Segmentation

As per the scope of this report, a cell viability assay is used to determine the ability of organs, cells, or tissues to maintain or recover viability. This type of assay can check the mechanical activity, motility, contraction, etc. Counting cells using viability dyes can provide both the proliferation rate and the percentage of viable cells. The cell viability assays market is segmented by product (consumables (reagents, assay kits, and other consumables), instruments (automated cell counters, flow cytometers, spectrophotometers, and other instruments)), application (drug discovery and development, stem cell research, clinical and diagnostic applications, and other applications), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD) for the above segments.

By Product Consumables Reagents
Assay Kits
Other Consumables
By Instruments Automated Cell Counters
Flow Cytometers
Spectrophotometers
Other Instruments
By Application Drug Discovery and Development
Stem Cell Research
Clinical and Diagnostic Applications
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cell Viability Assays Market Research FAQs

How big is the Cell Viability Assays Market?

The Cell Viability Assays Market size is expected to reach USD 1.87 billion in 2025 and grow at a CAGR of 7.70% to reach USD 2.72 billion by 2030.

What is the current Cell Viability Assays Market size?

In 2025, the Cell Viability Assays Market size is expected to reach USD 1.87 billion.

Who are the key players in Cell Viability Assays Market?

Thermo Fischer Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Becton Dickinson & Company and Abcam PLC are the major companies operating in the Cell Viability Assays Market.

Which is the fastest growing region in Cell Viability Assays Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Cell Viability Assays Market?

In 2025, the North America accounts for the largest market share in Cell Viability Assays Market.

What years does this Cell Viability Assays Market cover, and what was the market size in 2024?

In 2024, the Cell Viability Assays Market size was estimated at USD 1.73 billion. The report covers the Cell Viability Assays Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Cell Viability Assays Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Cell Viability Assays Industry Report

Statistics for the 2025 Cell Viability Assays market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cell Viability Assays analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.